bonilla

  1. forestglip

    Surface Protein Profiling of Extracellular Vesicles: A Novel Biomarker Approach for Long COVID Diagnosis?, 2025, Ikeda et al

    Surface Protein Profiling of Extracellular Vesicles: A Novel Biomarker Approach for Long COVID Diagnosis? Gentaro Ikeda, Prasanna Jagannathan, Mario Leki, Hiroyuki Inoue, Vanessa El Kamari, Arya V Dadhania, Mitchell Miglis, Robert W Shafer, Linda N Geng, Phillip C Yang, Hector F Bonilla...
  2. Andy

    Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 2023 Bonilla et al

    Highlights The off-label use of low-dose naltrexone (LDN) is a potential drug intervention for the management of post-COVID conditions. LDN has anti-inflammatory and immunomodulatory properties which may benefit those with PASC where persistent inflammation is the causative pathway. LDN...
  3. Andy

    [Ongoing]Cross-sectional study to assess the prevalence of APOE e4 alleles in pwME/CFS & association with herpes virus infection, 2019, Bonilla

    SMCI Ramsay Award recipient and new researcher to the field. https://solvecfs.org/hector-bonilla/
    • Andy
    • Thread
    • 2019 apoe bonilla herpesvirus me/cfs
    • Replies: 3
    • Forum: ME/CFS research
Back
Top Bottom